Seeing Is Believing
Currently out of the existing stock ratings of Kevin Heal, 62 are a BUY (84.93%), 10 are a HOLD (13.7%), 1 are a SELL (1.37%).
Analyst Kevin Heal, carries an average stock price target met ratio of 70.44% that have a potential upside of 20.97% achieved within 299 days. Previously, Kevin Heal worked at ARGUS.
Kevin Heal’s has documented 137 price targets and ratings displayed on 19 stocks. The coverage was on the Financial Services sector.
Most recent stock forecast was given on NDAQ, Nasdaq at 05-Nov-2024.
Analyst best performing recommendations are on RF (REGIONS FINANCIAL).
The best stock recommendation documented was for CMA (COMERICA) at 10/30/2023. The price target of $52 was fulfilled within 45 days with a profit of $15.75 (43.45%) receiving and performance score of 9.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$11
$0.62 (5.97%)
$11
1 months 6 days ago
(30-Jan-2025)
3/16 (18.75%)
$1.04 (10.44%)
401
Buy
$10.25
$-0.13 (-1.25%)
$10.25
1 months 6 days ago
(30-Jan-2025)
3/3 (100%)
$0.29 (2.91%)
172
Buy
$10.25
$-0.13 (-1.25%)
$10.25
1 months 7 days ago
(29-Jan-2025)
5/10 (50%)
$0.54 (5.56%)
130
Hold
$9.5
$-0.88 (-8.48%)
$9.75
1 months 26 days ago
(10-Jan-2025)
3/9 (33.33%)
$0.47 (5.20%)
98
Buy
$9.5
$-0.88 (-8.48%)
$11
2 months 2 days ago
(06-Jan-2025)
2/5 (40%)
$0.29 (3.15%)
185
Which stock is Kevin Heal is most bullish on?
Which stock is Kevin Heal is most reserved on?
What Year was the first public recommendation made by Kevin Heal?